Is Avenue Therapeutics, Inc. (ATXI) a Buy, Sell, or Hold?
OTC : ATXI
Avenue Therapeutics, Inc.
$0.25 USD
-$0.01 (-3.85%)
- Volume
- 1K
- Average Volume
- 2.79K
- Market Capitalization
- $823.74K
- P/E Ratio
- -0.47
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $0.97
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.90
| Source | Headline |
|---|---|
|
Comparing Avenue Therapeutics (NASDAQ:ATXI) & Graybug Vision (NASDAQ:GRAY)
Insider and Institutional Ownership 17.3% of Avenue Therapeutics shares are held by institutional investors. Comparatively, 49.9% of Graybug Vision shares are held by institutional investors. 8.6% of Avenue Therapeutics shares are held by company insiders. Comparatively, 7.9% of Graybug Vision shares are held by company insiders. Strong institutional ownership is an indication that large money defenseworld.net - 2026-04-25 02:30:52 |
